These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12213473)
41. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258 [TBL] [Abstract][Full Text] [Related]
42. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse. Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168 [TBL] [Abstract][Full Text] [Related]
43. 3-Aryl-2-carbomethoxybicyclo[3.2.1]oct-2-enes inhibit WIN 35,428 binding potently and selectively at the dopamine transporter. Meltzer PC; Blundell P; Huang H; Liu S; Yong YF; Madras BK Bioorg Med Chem; 2000 Mar; 8(3):581-90. PubMed ID: 10732975 [TBL] [Abstract][Full Text] [Related]
44. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845 [TBL] [Abstract][Full Text] [Related]
45. Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter. Simoni D; Roberti M; Rondanin R; Baruchello R; Rossi M; Invidiata FP; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A Bioorg Med Chem Lett; 2001 Mar; 11(6):823-7. PubMed ID: 11277529 [TBL] [Abstract][Full Text] [Related]
46. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites. Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962 [TBL] [Abstract][Full Text] [Related]
47. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Hitri A; Hurd YL; Wyatt RJ; Deutsch SI Clin Neuropharmacol; 1994 Feb; 17(1):1-22. PubMed ID: 8149355 [TBL] [Abstract][Full Text] [Related]
48. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter. Husbands SM; Izenwasser S; Loeloff RJ; Katz JL; Bowen WD; Vilner BJ; Newman AH J Med Chem; 1997 Dec; 40(26):4340-46. PubMed ID: 9435903 [TBL] [Abstract][Full Text] [Related]
49. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors. Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857 [TBL] [Abstract][Full Text] [Related]
54. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents. Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223 [TBL] [Abstract][Full Text] [Related]
55. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565 [TBL] [Abstract][Full Text] [Related]
56. An analysis of the binding of cocaine analogues to the monoamine transporters using tensor decomposition 3-d QSAR. Appell M; Dunn WJ; Reith ME; Miller L; Flippen-Anderson JL Bioorg Med Chem; 2002 May; 10(5):1197-206. PubMed ID: 11886784 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives. Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910 [TBL] [Abstract][Full Text] [Related]
58. In vivo regulation of central nervous system progesterone receptors: cocaine induces steroid-dependent behavior through dopamine transporter modulation of D5 receptors in rats. Apostolakis EM; Garai J; Clark JH; O'Malley BW Mol Endocrinol; 1996 Dec; 10(12):1595-604. PubMed ID: 8961269 [TBL] [Abstract][Full Text] [Related]
59. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. Lin Z; Uhl GR Mol Pharmacol; 2002 Apr; 61(4):885-91. PubMed ID: 11901228 [TBL] [Abstract][Full Text] [Related]